Methods for simultaneous quantification of thyroid hormones and metabolites thereof by mass spectrometry

US9012835B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9012835-B2
Application numberUS-201113881602-A
CountryUS
Kind codeB2
Filing dateNov 7, 2011
Priority dateNov 8, 2010
Publication dateApr 21, 2015
Grant dateApr 21, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides methods for simultaneously detecting or simultaneously quantifying any combination of thyroxine (T 4 ), triiodothyronine (T 3 ), 3,3′-diiodo-L-thyronine (3,3′-T 2 ), 3-iodothyronamine (T 1 AM), and, optionally, reverse T 3 (rT 3 ) in a sample obtained from a human. The method involves a simple, sensitive, accurate, and specific isotope dilution tandem mass spectrometry method for the simultaneous quantification of any combination of T 4 , T 3 , 3,3′-T 2 , T 1 AM, and, optionally, rT 3 in a sample obtained from a human, e.g., in human plasma or serum samples. This assay is far more sensitive than previously described assays for thyronamines and allows quantitation of T 1 AM in human plasma or serum, including from healthy controls.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of simultaneously assaying thyroxine (T 4 ), triiodothyronine (T 3 ), 3,3′-diiodo-L-thyronine (3,3′-T 2 ), and 3-iodothyronamine (T 1 AM), comprising: a) providing a test sample, wherein the test sample comprises T 4 , T 3 , 3,3′-T 2 , and T 1 AM; b) providing a calibration sample, wherein the calibration sample comprises known quantities of reference T 4 , T 3 , 3,3′-T 2 , and T 1 AM; c) combining the test sample with the calibration sample;…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9012835B2 cover?
The invention provides methods for simultaneously detecting or simultaneously quantifying any combination of thyroxine (T 4 ), triiodothyronine (T 3 ), 3,3′-diiodo-L-thyronine (3,3′-T 2 ), 3-iodothyronamine (T 1 AM), and, optionally, reverse T 3 (rT 3 ) in a sample obtained from a human. The method involves a simple, sensitive, accurate, and specific isotope dilution tandem mass spectrometry m…
Who is the assignee on this patent?
Soldin Steven J, Soldin Offie P, Univ Georgetown
What technology area does this patent fall under?
Primary CPC classification G01N33/6848. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).